Although a low volume stock to begin with. The volumes here have woken up as of late.
Could we be nearing our trial expansion news?
There was an expectation to issue an update in January. It never came.
No biggie. Volume leads me to believe we could get impressive news immanently.
Company has posted a lot on good news to Sedar for a year or so.
When the founder tragically passed. The company entered into a strategic down period. The educational capital of the founder was lost. Often the drivers of these stocks are a large part of their success. Dr. Krantz was that man to this stock.
Now with his studies and work experience sufficient to do so. The founders son. Dr. Benjamin Krantz. Will take over leading the company that his father founded.
Due to this unforeseen circumstance. It crushed the stock. Allowed for a strategic down down period. Stock was rolled back. His son, and insiders loaded up.
One of those stocks. Buy hold. One day you're gonna wake up with a 10x+. These guys have a chance to piggy back some pretty massive pre existing drugs. If they can score a licence. Big time blue sky potential.
Stat tuned!!